Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.

Diabetes Care
Aparna PalKatharine R Owen

Abstract

Assignment of the correct molecular diagnosis in diabetes is necessary for informed decisions regarding treatment and prognosis. Better clinical markers would facilitate discrimination and prioritization for genetic testing between diabetes subtypes. Serum 1,5 anhydroglucitol (1,5AG) levels were reported to differentiate maturity-onset diabetes of the young due to HNF1A mutations (HNF1A-MODY) from type 2 diabetes, but this requires further validation. We evaluated serum 1,5AG in a range of diabetes subtypes as an adjunct for defining diabetes etiology. 1,5AG was measured in U.K. subjects with: HNF1A-MODY (n = 23), MODY due to glucokinase mutations (GCK-MODY, n = 23), type 1 diabetes (n = 29), latent autoimmune diabetes in adults (LADA, n = 42), and type 2 diabetes (n = 206). Receiver operating characteristic curve analysis was performed to assess discriminative accuracy of 1,5AG for diabetes etiology. Mean (SD range) 1,5AG levels were: GCK-MODY 13.06 microg/ml (5.74-29.74), HNF1A-MODY 4.23 microg/ml (2.12-8.44), type 1 diabetes 3.09 microg/ml (1.45-6.57), LADA 3.46 microg/ml (1.42-8.45), and type 2 diabetes 5.43 (2.12-13.23). Levels in GCK-MODY were higher than in other groups (P < 10(-4) vs. each group). HNF1A-MODY subjects sh...Continue Reading

References

Aug 1, 1992·Metabolism: Clinical and Experimental·T YamanouchiI Akaoka
Aug 29, 1996·Biochimica Et Biophysica Acta·T YamanouchiH Miyashita
Oct 31, 1998·Diabetic Medicine : a Journal of the British Diabetic Association·R MenzelS Menzel
Jul 3, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·E S KilpatrickG M Addison
Mar 28, 2001·EMBO Reports·M PontoglioG Friedlander
Sep 14, 2001·Best Practice & Research. Clinical Endocrinology & Metabolism·K Owen, A T Hattersley
Oct 25, 2003·Lancet·Ewan R PearsonAndrew T Hattersley
Nov 9, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·William NowatzkeThomas G Cole
Apr 8, 2006·European Journal of Pediatrics·E FeigerlováT Hansen
Jul 25, 2007·Archives of Internal Medicine·Elizabeth SelvinJosef Coresh
Feb 26, 2008·Diabetologia·S EllardUNKNOWN European Molecular Genetics Quality Network (EMQN) MODY group
Feb 28, 2008·Nature Clinical Practice. Endocrinology & Metabolism·Rinki MurphyAndrew T Hattersley

❮ Previous
Next ❯

Citations

Mar 2, 2011·Annals of Internal Medicine·Elizabeth SelvinFrederick L Brancati
Aug 1, 2012·Endocrine·Won Jun Kim, Cheol-Young Park
Jan 18, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Elizabeth SelvinMichael W Steffes
Jan 1, 2013·Diabetes·Gaya ThanabalasinghamAlan F Wright
May 26, 2017·Diabetes Technology & Therapeutics·Lorena Alarcon-Casas Wright, Irl B Hirsch
Jan 16, 2016·Metabolomics : Official Journal of the Metabolomic Society·Henk den OudenJoline W J Beulens
Jun 13, 2020·Diabetology & Metabolic Syndrome·Renata Peixoto-BarbosaFernando M A Giuffrida
Oct 30, 2020·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Priya DesaiJoon Young Kim
Feb 3, 2021·The Journal of Clinical Investigation·Haichen ZhangToni I Pollin
Jul 24, 2013·Annals of Clinical Biochemistry·Tim J McDonald, Sian Ellard

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.